CD19 and acute lymphoblastic leukemia: Selective pressure to mutate CD19 and outgrowth of pre-existing rare CD19-negative cells are considered as the major mechanisms of relapsed ALL cells escaping anti-CD19 CAR-T cells killing (95, 96).